semaglutide and breast cancer GLP-1 use linked to lower incidence in large cohort study can semaglutide cause breast cancer

While both affect how the body functions, they work differently

S.SamG.et al (2023)

For patients seeking synergistic benefits, PlexusDx GLP-Squared combines semaglutide and tirzepatide in a single injection, at $289/mo month-to-month, or from $249/mo on the 6-month plan

These findings indicate that liraglutide, semaglutide, and tirzepatide were each associated with significant improvements in liver enzyme levels over the 36-week treatment period, without evidence of differential effects between agents (Table 6 and Figure 4)

To improve glycemic control, it activates the GLP-1 receptor, which leads to an increase in insulin secretion, a decrease in glucagon production, and a slowing of stomach emptying

But I also believe in staying curious, following the science, and being willing to change my mind when the evidence demands it